Consultancy

Medicines funding report

The NHS landscape is evolving. With crucial changes to funding models and new formulary arrangements emerging at system and place levels, in a new report Wilmington Healthcare explores what the reforms mean for drug funding and how industry must adapt.

Available to purchase now, please register your interest below.

Consultancy services

We support pharma, medtech, patient charities and the NHS in the innovation, adoption and implementation of services and products.

With our depth and breadth of NHS and healthcare industry experience we are an enabler of change for our clients and the NHS.

Improving care pathways

Our Healthcare Consultancy team helps customers to engage with NHS transformation leads, commissioners, providers, procurement and clinicians by evaluating the variation between optimal and suboptimal patient pathways and developing economic value propositions using our unique methodology to create Costed Integrated Patient Scenarios.
Our Costed Integrated Patient Scenarios are presented in an NHS-aligned patient case format, creating relatable stories that are essential for communicating the impact across multidisciplinary teams.

Optimising commercial effectiveness

Commercial Optimisation is our market-leading healthcare consultancy service that maximises the commercial effectiveness of go-to-market strategies for Pharma and MedTech.

Enhancing the go-to-market process at any stage of the product lifecycle, Commercial Optimisation utilises real-world evidence and cutting-edge analytic tools to deliver data-driven insights that identify the NHS localities and customers offering maximum commercial opportunity.